SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-60,000
-300,000 vol
$0.20 each 		750,000
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$60,000
+300,000 vol
$0.20 each 		513,750
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,937
+6,250 vol
$0.95 each 		213,750
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Holder: Cindy Eikens-Stafford (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$5,937
+6,250 vol
$0.95 each 		68,750
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-101,250
-250,000 vol
$0.405 each 		500,000
Filed 2019-01-09
Tx date 2019-01-04 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$101,250
+250,000 vol
$0.405 each 		763,750
Filed 2018-11-30
Tx date 2017-05-05 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$119,952
+239,904 vol
$0.50 each
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		12,625,496
Filed 2018-11-30
Tx date 2018-05-25 		$MPX
MPX Bioceutical Corporation 		Singh, Krishna Pal
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
11 - Acquisition or disposition carried out privately
+$9,235,795 vol 		$15,735,795
Filed 2018-11-30
Tx date 2018-05-25 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
11 - Acquisition or disposition carried out privately
+$9,235,795 vol 		$15,735,795
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Krishna Pal
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		12,625,496
Filed 2018-11-30
Tx date 2017-10-17 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
11 - Acquisition or disposition carried out privately
+$6,500,000 vol 		$6,500,000
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Krishna Pal
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2017-05-05 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$119,952
+239,904 vol
$0.50 each
Filed 2018-11-30
Tx date 2017-05-05 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$119,952
+239,904 vol
$0.50 each 		12,865,400
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2017-03-31 		$MPX
MPX Bioceutical Corporation 		Singh, Martha Jane
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2017-05-05 		$MPX
MPX Bioceutical Corporation 		Singh, Krishna Pal
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$119,952
+239,904 vol
$0.50 each 		12,865,400
Filed 2018-11-30
Tx date 2017-10-17 		$MPX
MPX Bioceutical Corporation 		Singh, Krishna Pal
3 - 10% Security Holder of Issuer
Holder: Hi-Med, LLC (Control or Direction)
Promissory Notes
11 - Acquisition or disposition carried out privately
+$6,500,000 vol 		$6,500,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-202,500
-500,000 vol
$0.405 each 		3,500,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,100,000
-3,500,000 vol
$0.60 each 		4,000,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$202,500
+500,000 vol
$0.405 each 		7,500,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-700,000
-3,500,000 vol
$0.20 each 		7,500,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$700,000
+3,500,000 vol
$0.20 each 		3,500,000
Filed 2018-11-20
Tx date 2018-11-16 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$2,100,000
+3,500,000 vol
$0.60 each 		7,000,000
Filed 2018-11-20
Tx date 2017-01-23 		$MPX
MPX Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-30
Tx date 2018-10-30 		$MPX
MPX Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$121,500
+300,000 vol
$0.405 each 		530,000
Filed 2018-10-30
Tx date 2018-10-30 		$MPX
MPX Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$121,500
+300,000 vol
$0.405 each 		530,000
Filed 2018-06-04
Tx date 2018-05-31 		$MPX
MPX Bioceutical Corporation 		Petch, Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$607,500
+750,000 vol
$0.81 each 		750,000
Filed 2018-06-04
Tx date 2018-05-31 		$MPX
MPX Bioceutical Corporation 		Petch, Robert
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-01
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-01
Tx date 2018-02-13 		$MPX
MPX Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$80,500
+230,000 vol
$0.35 each 		230,000
Filed 2018-03-01
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-01
Tx date 2018-02-13 		$MPX
MPX Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$80,500
+230,000 vol
$0.35 each 		230,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Budd, Jeremy
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$645,000
+750,000 vol
$0.86 each 		900,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		McLaren, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$860,000
+1,000,000 vol
$0.86 each 		1,000,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Thompson, Miles D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		750,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		1,050,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Segerbloom, Richard S.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		750,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		750,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		McLaren, David
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		750,000
Filed 2018-01-16
Tx date 2018-01-15 		$MPX
MPX Bioceutical Corporation 		Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$430,000
+500,000 vol
$0.86 each 		1,000,000
Filed 2017-12-22
Tx date 2017-12-21 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-2,148,500 vol 		25,121,000
Filed 2017-12-21
Tx date 2017-12-20 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-3,805,000 vol 		27,269,500
Filed 2017-12-20
Tx date 2017-12-19 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-898,500 vol 		31,074,500
Filed 2017-12-19
Tx date 2017-12-18 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-950,000 vol 		31,973,000
Filed 2017-12-18
Tx date 2017-12-15 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-971,500 vol 		32,923,000
Filed 2017-12-15
Tx date 2017-12-14 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-1,184,000 vol 		33,894,500
Filed 2017-12-14
Tx date 2017-12-13 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-1,801,000 vol 		35,078,500
Filed 2017-12-13
Tx date 2017-12-12 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-1,933,500 vol 		36,879,500
Filed 2017-12-12
Tx date 2017-12-11 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-2,332,000 vol 		38,813,000
Filed 2017-12-11
Tx date 2017-12-08 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-1,510,000 vol 		41,145,000
Filed 2017-12-08
Tx date 2017-12-07 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-236,500 vol 		42,655,000
Filed 2017-12-07
Tx date 2017-12-06 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-443,000 vol 		42,891,500
Filed 2017-12-06
Tx date 2017-12-05 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-72,000 vol 		43,334,500
Filed 2017-12-05
Tx date 2017-12-04 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-143,500 vol 		43,406,500
Filed 2017-12-04
Tx date 2017-12-01 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-31,000 vol 		43,550,000
Filed 2017-12-04
Tx date 2017-11-30 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-897,000 vol 		43,581,000
Filed 2017-11-30
Tx date 2017-11-29 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-352,000 vol 		44,478,000
Filed 2017-11-29
Tx date 2017-11-28 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-1,294,000 vol 		44,830,000
Filed 2017-11-28
Tx date 2017-11-27 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-3,394,500 vol 		46,124,000
Filed 2017-11-28
Tx date 2017-11-15 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-68,500 vol 		51,911,000
Filed 2017-11-28
Tx date 2017-11-15 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-68,000 vol
Filed 2017-11-27
Tx date 2017-11-24 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-754,500 vol 		49,519,000
Filed 2017-11-27
Tx date 2017-11-23 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-250,500 vol 		50,273,500
Filed 2017-11-23
Tx date 2017-11-21 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-538,000 vol 		50,524,000
Filed 2017-11-22
Tx date 2017-11-20 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-378,000 vol 		51,062,000
Filed 2017-11-20
Tx date 2017-11-17 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-196,000 vol 		51,440,000
Filed 2017-11-20
Tx date 2017-11-16 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-275,500 vol 		51,636,000
Filed 2017-11-16
Tx date 2017-11-15 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-68,000 vol 		51,911,500
Filed 2017-11-16
Tx date 2017-11-14 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-183,000 vol 		51,979,500
Filed 2017-11-16
Tx date 2017-11-13 		$MPX
MPX Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-337,500 vol 		52,162,500
Filed 2017-11-03
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$202,500
+500,000 vol
$0.405 each 		4,150,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Thompson, Miles D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$101,250
+250,000 vol
$0.405 each 		250,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Thompson, Miles D.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$202,500
+500,000 vol
$0.405 each 		11,000,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$101,250
+250,000 vol
$0.405 each 		550,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Segerbloom, Richard S.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$101,250
+250,000 vol
$0.405 each 		250,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Segerbloom, Richard S.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$101,250
+250,000 vol
$0.405 each 		250,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$101,250
+250,000 vol
$0.405 each 		250,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
The Canadian Bioceutical Corporation 		Galvin, Robert R.
4 - Director of Issuer
Holder: ARG Advisory Services LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,040,986
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Ryan, Andrew R.
4 - Director of Issuer
Holder: ARG Advisory Services LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,040,986
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Budd, Jeremy
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		150,000
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Budd, Jeremy
5 - Senior Officer of Issuer
Holder: Samantha Barkin Budd (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		108,333
Filed 2017-11-02
Tx date 2017-10-30 		$MPX
MPX Bioceutical Corporation 		Budd, Jeremy
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		400,167
Filed 2015-06-17
Tx date 2015-06-12 		$MPX
Maple Power Capital Corporation 		Mitchell, David
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-131,250 vol 		43,750
Filed 2015-06-17
Tx date 2015-06-12 		$MPX
Maple Power Capital Corporation 		Mitchell, David
4 - Director of Issuer
Holder: Stillbridge Ventures Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-150,000 vol 		50,000